Drug Type Chemical drugs |
Synonyms Metabolic disorders(Septerna) |
Target |
Mechanism GCGR agonists(Glucagon receptor agonists), GIPR agonists(Gastric inhibitory polypeptide receptor agonists), GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization ![]() |
Active Organization ![]() |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metabolic Diseases | Preclinical | US | ![]() | 08 May 2024 |
Diabetes Mellitus, Type 2 | Discovery | US | ![]() | 01 Feb 2025 |
Obesity | Discovery | US | ![]() | 01 Feb 2025 |